Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

Stock futures are slightly higher Thursday as the market looks to rebound from a couple of lackluster days, with investors ...

though stock investors didn't seem too concerned. All three major indexes were muted in morning trading. In recent trading: ...

The stock that’s become most entwined with Trump’s popularity ... The Dow dropped 382.15 to 43,910.98, and the Nasdaq ...

CleanSpark shows strong growth in Bitcoin mining with increased hashrate, energy efficiency, and strategic partnerships.

Stock futures gave back earlier gains after wholesale price inflation ticked higher in October. The producer price index rose 0.2% in October, which matched the consensus estimate among economists.

In recent trading: Stock futures were slightly higher. On Wednesday, the S&P 500 and Dow industrials finished slightly higher, while the Nasdaq Composite fell. Treasury yields were little changed, ...

This darling stock is growing revenue at an extraordinary rate and believes it can grow at a greater than 20% annual rate ...

Trump fills out cabinet picks, Cisco raises outlook, Super Micro stock faces delisting, and other news to start your day.

Shares were mixed in Asia on Thursday after a lackluster finish on Wall Street following a report showing an uptick last ...

Apple (NASDAQ: AAPL) went public in 1980 at a price of $22 per share ... before ultimately becoming the first company to reach a $3 trillion valuation. Let's examine how Apple's stock splits have ...